pharmaceutical investing ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
medical device investing Predictive Technology Announces Completion of Genotyping in Two Clinical Trials of ARTGuide
medical device investing ChroMedX CEO Lahav Gil Assembles Task-Force to Explore Feasibility and Applications of Automated Ultrafiltration Technology
medical device investing U.S. Patent and Trademark Office has granted to Todos Medical two additional patents
medical device investing ChroMedX Announces In-House Biosensor Manufacturing for Expedited Testing and Refinement; Appoints Edwards as Executive Chairman
medical device investing RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
Charbone Hydrogene Annonce un Financement de Reglements de Dettes par Emission d'Unites pour un Montant Total de 1,3M$
Cartier Signs Agreement with Exploits Discovery To Option 100% of the Benoist, Fenton and Wilson Properties Â
